{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T14:39:52Z","timestamp":1780065592279,"version":"3.54.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1016\/j.jaad.2005.11.1072","type":"journal-article","created":{"date-parts":[[2006,6,16]],"date-time":"2006-06-16T08:06:08Z","timestamp":1150445168000},"page":"139-142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Acne in recipients of renal transplantation treated with sirolimus: Clinical, microbiologic, histologic, therapeutic, and pathogenic aspects"],"prefix":"10.1016","volume":"55","author":[{"given":"Emmanuel","family":"Mah\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Morelon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Lechaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe","family":"Drappier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"de Prost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri","family":"Kreis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Bodemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2005.11.1072_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1523-1755.2001.00460.x","article-title":"Rapamycin in transplantation: a review of the evidence","volume":"59","author":"Saunders","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.jaad.2005.11.1072_bib2","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1097\/00007890-199904150-00017","article-title":"Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine; sirolimus European renal transplant study group","volume":"67","author":"Groth","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.jaad.2005.11.1072_bib3","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0140-6736(00)02480-6","article-title":"Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomized multicenter study: the Rapamune US study group","volume":"356","author":"Kahan","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2005.11.1072_bib4","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00007890-200101270-00019","article-title":"A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus\/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts","volume":"71","author":"MacDonald","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.jaad.2005.11.1072_bib5","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1097\/01.TP.0000071301.86299.75","article-title":"A prospective randomized multicenter study of tacrolimus in combination with sirolimus in renal-transplant recipients","volume":"75","author":"Van Hooff","year":"2003","journal-title":"Transplantation"},{"issue":"Suppl","key":"10.1016\/j.jaad.2005.11.1072_bib6","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1016\/S0041-1345(03)00244-6","article-title":"Sirolimus therapy without calcineurin inhibitors: Necker Hospital 8-year experience","volume":"35","author":"Morelon","year":"2003","journal-title":"Transplant Proc"},{"issue":"Suppl","key":"10.1016\/j.jaad.2005.11.1072_bib7","doi-asserted-by":"crossref","first-page":"S201","DOI":"10.1016\/S0041-1345(03)00231-8","article-title":"Rapamycin in combination with cyclosporine or tacrolimus in liver, pancreas, and kidney transplantation","volume":"35","author":"MacDonald","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jaad.2005.11.1072_bib8","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1097\/01.ASN.0000113248.59077.76","article-title":"Long-term benefits with sirolimus-based therapy after early cyclosporine withdrawal","volume":"15","author":"Kreis","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jaad.2005.11.1072_bib9","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1046\/j.1365-2133.2001.04376.x","article-title":"Efficacy of sirolimus (rapamycin) administered concomitantly with a subtherapeutic dose of cyclosporin in the treatment of severe psoriasis: a randomized controlled trial","volume":"145","author":"Reitamo","year":"2001","journal-title":"Br J Dermatol"},{"issue":"Suppl","key":"10.1016\/j.jaad.2005.11.1072_bib10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jaad.2004.05.044","article-title":"Rapamycin (sirolimus) as a steroid-sparing agent in dermatomyositis","volume":"52","author":"Nadiminti","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2005.11.1072_bib11","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1046\/j.1365-2249.1996.d01-651.x","article-title":"The effects of the immunosuppressant rapamycin on the growth of rheumatoid arthritis (RA) synovial fibroblasts","volume":"104","author":"Migita","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaad.2005.11.1072_bib12","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1097\/01.TP.0000056639.74982.F9","article-title":"Oral ulcers in kidney transplant recipients treated with sirolimus and mycophenolate mofetil","volume":"75","author":"Van Gelder","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.jaad.2005.11.1072_bib13","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/00007890-200107150-00031","article-title":"Sirolimus-associated eyelid edema in kidney transplant recipients","volume":"72","author":"Mohaupt","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.jaad.2005.11.1072_bib14","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1097\/01.TP.0000118406.01509.75","article-title":"Lymphedema associated with sirolimus in renal transplant recipients","volume":"77","author":"Aboujaoude","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.jaad.2005.11.1072_bib15","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/01.TP.0000151630.25127.3A","article-title":"Cutaneous adverse events in renal transplant recipients receiving sirolimus-based therapy","volume":"79","author":"Mah\u00e9","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.jaad.2005.11.1072_bib16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/mc.10140","article-title":"Involvement of the Akt\/mTOR pathway on EGF-induced cell transformation","volume":"38","author":"Nomura","year":"2003","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.jaad.2005.11.1072_bib17","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1046\/j.1365-2133.2001.04226.x","article-title":"Cutaneous side effects in cancer patients treated with the antiepidermal growth factor receptor antibody C225","volume":"144","author":"Busam","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2005.11.1072_bib18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/00015550310005898","article-title":"Cutaneous side effects in non-small cell lung cancer patients treated with Iressa (ZD1839), an inhibitor of epidermal growth factor","volume":"84","author":"Lee","year":"2004","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2005.11.1072_bib19","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1158\/1078-0432.CCR-03-0564","article-title":"United States Food and Drug Administration drug approval summary: gefitinib (ZD1839; Iressa) tablets","volume":"10","author":"Cohen","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jaad.2005.11.1072_bib20","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1200\/JCO.2004.10.182","article-title":"Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor","volume":"22","author":"Saltz","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2005.11.1072_bib21","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1210\/endo-128-4-2141","article-title":"Pretranslational enhancement of epidermal growth factor receptor by direct effect of testosterone in mouse liver","volume":"128","author":"Noguchi","year":"1991","journal-title":"Endocrinology"},{"key":"10.1016\/j.jaad.2005.11.1072_bib22","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1046\/j.1600-6135.2003.00279.x","article-title":"Testosterone concentrations and sirolimus in male renal transplant patients","volume":"4","author":"Fritsche","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jaad.2005.11.1072_bib23","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1600-6143.2005.00604.x","article-title":"Sirolimus impairs improvement of the gonadal function after renal transplantation","volume":"5","author":"Tondolo","year":"2005","journal-title":"Am J Transplant"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962205046025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962205046025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:02:26Z","timestamp":1759269746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962205046025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S0190962205046025"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2005.11.1072","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acne in recipients of renal transplantation treated with sirolimus: Clinical, microbiologic, histologic, therapeutic, and pathogenic aspects","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2005.11.1072","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}